Skip to content

Digoxin

Introduction

The AF Association is working to provide information, support and access to established, new or innovative treatments for atrial fibrillation.

We are currently conducting a survey relating to the medication Digoxin.

Have you prescribed Digoxin to a patient, as we are seeking your experience about the medication. This will help provide us with a full understanding of the medication. Your feedback is a valued component in helping understand the efficacy of the medication.

Therefore, we are seeking your support by completing the brief survey below, which should take no more than 5-10 minutes of your time.
1.Have you prescribed Digoxin?
2.Which conditions do you prescribe Digoxin for?
If yes, can you list some examples:
3.Have you seen any changes in the levels of Digoxin once prescribed in the last 5-10 years?
4.How do you monitor Digoxin toxicity in patients?
Can you list some examples:
5.Did you provide the patient with an overview about Digoxin and functionality in the body in advance?
6.Did the overview include signs of toxicity (elevated levels of Digoxin in the body), or how to recognise toxicity symptoms, such as an information sheet or discussion guide?
7.Are you aware of any patients experiencing side effects since taking Digoxin?
8.If a patient suspects Digoxin toxicity, have they been provided with an urgent procedure to follow immediately?
Thank you for your participation.

Your responses are confidential and will not be shared with any third parties.